Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Classifying hepatitis C virus genotypes

Y Miyakawa1, H Okamoto, M Mayumi

  • 1Mita Institute, Tokyo, Japan.

Molecular Medicine Today
|April 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Xenopus homologue of the human beta-amyloid precursor protein: developmental regulation of its gene expression.

Biochemical and biophysical research communications·1992
Same author

Full-length nucleotide sequence of a Japanese hepatitis C virus isolate (HC-J1) with high homology to USA isolates.

Nucleic acids research·1992
Same author

Quantitative HCV RNA and effect of interferon therapy in chronic hepatitis C.

Digestive diseases and sciences·1992
Same author

Chemotherapy-induced anemia in patients with primary lung cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·1992
Same author

[Analyses of Na, K-ATPase subunit genes].

Nihon rinsho. Japanese journal of clinical medicine·1992
Same author

[Successful repair of traumatic aortic arch rupture].

[Zasshi] [Journal]. Nihon Kyobu Geka Gakkai·1992
Same journal

Have tumor cells learnt from microorganisms how to fool the immune system? Escape from immune surveillance of tumors and microorganisms: emerging mechanisms and shared strategies.

Molecular medicine today·2001
Same journal

Molecular signalling in cardiovascular biology: from molecules to man. International symposium organized by the centre for cardiovascular biology and medicine, King's College, London.

Molecular medicine today·2001
Same journal

Is successful gene therapy for retinal disease in sight?

Molecular medicine today·2001
Same journal

New imaging techniques for early diagnosis of Alzheimer's disease.

Molecular medicine today·2001
Same journal

Knocking out NEMO.

Molecular medicine today·2001
Same journal

Clinical gene therapy back in the race.

Molecular medicine today·2001
See all related articles

Hepatitis C virus (HCV) exhibits over 28 genotypes, influencing global health. These distinct viral strains impact replication, disease progression, and treatment effectiveness in chronic hepatitis C patients.

Area of Science:

  • Virology
  • Hepatology
  • Infectious Diseases

Background:

  • Hepatitis C virus (HCV) is a primary cause of non-A, non-B hepatitis globally.
  • Over 28 distinct HCV genotypes have been identified since 1989.
  • Genomic differences, exceeding 20% in nucleotide sequences, define these genotypes.

Purpose of the Study:

  • To highlight the significance of Hepatitis C virus (HCV) genotypes.
  • To underscore the genetic diversity and classification of HCV.
  • To explore the implications of HCV genotypes on disease characteristics and treatment.

Main Methods:

  • Genomic sequencing to analyze nucleotide differences across the HCV genome.
  • Comparative analysis of E1 gene sequences (576 nucleotides).

Related Experiment Videos

  • Epidemiological data collection to map genotype distribution.

    • Main Results:

    • Identification of at least 28 distinct HCV genotypes.
    • Demonstration of significant nucleotide sequence variation (>20%) defining genotypes.
    • Association of specific genotypes with geographical distribution.

    Conclusions:

    • HCV genotypes possess unique geographical patterns.
    • Viral replication and pathogenicity may vary among genotypes.
    • HCV genotype influences treatment outcomes, particularly interferon response in chronic hepatitis C.